Optimized Cardioprotection Therapy in Obese Subjects With CAD

NCT04570527 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-09-30

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and mechanism of Adipokines Cardiac Protection in Obese Patients With coronary artery disease (CAD).

Conditions

  • Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
  • Obesity
  • Adiposis; Heart

Interventions

PROCEDURE

PCI

percutaneous coronary intervention

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Dongdong Sun, MD, PhD · Xijing Hospital

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-10-01
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570527 on ClinicalTrials.gov